UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreWinter 2025/2026 Myeloma Magazine
The goal of Myeloma is to provide timely updates about progress in clinical treatment and research advances, as well as stories and information of general interest.
Read MagazineMyeloma Center: Subaru of Little Rock, Blood Cancer United Show Support for UAMS Blood Cancer Patients
Subaru of Little Rock and Blood Cancer United continued their long-standing collaboration with the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute with donations for patients undergoing blood cancer treatment.
News & Announcements
Behind the Scenes
Majid Asgari, Ph.D. Majid Asgari, Ph.D., is a postdoctoral fellow in the UAMS College of Medicine Department of Internal Medicine. He earned his doctorate in medical biotechnology from the Pasteur Institute of Iran in 2021 and joined the UAMS Myeloma Center in 2024 in the lab of research director Fenghuang “Frank” Zhan, M.D., Ph.D. His…
Read more
Publications
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages Blood Cancer Journal November 2024 Primary authors: Yan Cheng, Ph.D.; Fumou Sun, Ph.D. Tumor immune microenvironmental alterations occur early in multiple myeloma development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor-immune interactions from precursor stages,…
Read more
Infusion B: A Welcoming Setting for Blood Cancer Patients
Five years after its opening, Infusion B at the Winthrop P. Rockefeller Cancer Institute continues to play a vital role in the transformational care that blood cancer patients receive at the University of Arkansas for Medical Sciences (UAMS).
Read more
Myeloma Patient Thankful for Chance to Participate in Clinical Trial
Gary Robertson thinks his multiple myeloma diagnosis came at good time, if such a thing is possible.
Read moreWant to read more stories like these?